Home » Topics » Regulatory

Regulatory
RSS

Further approval recommended for Novantrone

Sep. 20, 1996

New formulation of ciclosporin

Sep. 20, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Antibacterial compositions for MRSA

Sep. 20, 1996

A safe, effective and economical contraceptive method

Sep. 13, 1996

New treatment for diabetic keratopathy

Sep. 13, 1996

Mitsui Toatsu claims long-acting oral form of MS-551

Sep. 13, 1996

Nebivolol claimed for oxidative stress-related disorders

Sep. 13, 1996

Lilly reports new treatment for attention deficit/hyperactivity disorder

Sep. 13, 1996

Rhodanines for multiple sclerosis

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 6, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 6, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.